Universe Pharmaceuticals ... (UPC)
0.44
-0.08 (-15.38%)
At close: Jan 29, 2025, 3:58 PM
0.45
1.26%
After-hours Jan 29, 2025, 07:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -6.16M | -8.74M | 11.32M | 7.56M | 7.55M | 7.60M |
| Depreciation & Amortization | 508.79K | 533.95K | 446.88K | 410.08K | 418.43K | 452.73K |
| Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 1.45M | 10.02M | -10.82M | 713.52K | -166.52K | -654.88K |
| Other Non-Cash Items | -526.91K | 906.59K | -468.17K | 22.71K | 112.79K | -85.19K |
| Deferred Income Tax | 679.59K | -605.28K | -668.34K | -9.89K | -39.63K | 17.54K |
| Change in Working Capital | 6.62M | 6.59M | -12.69M | -1.87M | 5.16M | -3.53M |
| Operating Cash Flow | 1.12M | -1.31M | -2.06M | 6.12M | 13.20M | 4.46M |
| Capital Expenditures | -44.17K | -93.70K | -13.53M | -51.80K | -86.32K | -145.09K |
| Acquisitions | n/a | -3.81M | 26.62M | n/a | 291.00 | n/a |
| Purchase of Investments | n/a | n/a | -15.33M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | 1.80M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 523.00 | -26.62M | n/a | -0.00 | n/a |
| Investing Cash Flow | -44.17K | -3.91M | -27.06M | -51.80K | -86.03K | -145.09K |
| Debt Repayment | -1.39M | n/a | 624.35K | 911.20K | 1.14K | -1.85M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | -16.00M | -3.06M |
| Other Financial Acitivies | n/a | 3.32M | -2.79M | -441.06K | n/a | n/a |
| Financial Cash Flow | -1.39M | 3.32M | 26.58M | 470.14K | -16.00M | -4.91M |
| Net Cash Flow | -426.21K | -2.37M | -1.98M | 6.88M | -3.01M | -793.24K |
| Free Cash Flow | 1.08M | -1.41M | -15.59M | 6.06M | 13.12M | 4.31M |